Global Point of Care Diagnostics (POCD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Point of Care Diagnostics (POCD) market size was valued at USD 26410 million in 2023 and is forecast to a readjusted size of USD 35250 million by 2030 with a CAGR of 4.2% during review period.
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Point of Care Diagnostics (POCD) industry chain, the market status of Clinics (Blood Glucose Testing, Infectious Diseases Testing), Hospitals (Blood Glucose Testing, Infectious Diseases Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point of Care Diagnostics (POCD).
Regionally, the report analyzes the Point of Care Diagnostics (POCD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point of Care Diagnostics (POCD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point of Care Diagnostics (POCD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point of Care Diagnostics (POCD) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Glucose Testing, Infectious Diseases Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point of Care Diagnostics (POCD) market.
Regional Analysis: The report involves examining the Point of Care Diagnostics (POCD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point of Care Diagnostics (POCD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point of Care Diagnostics (POCD):
Company Analysis: Report covers individual Point of Care Diagnostics (POCD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point of Care Diagnostics (POCD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinics, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Point of Care Diagnostics (POCD). It assesses the current state, advancements, and potential future developments in Point of Care Diagnostics (POCD) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point of Care Diagnostics (POCD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point of Care Diagnostics (POCD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Point of Care Diagnostics (POCD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point of Care Diagnostics (POCD), with revenue, gross margin and global market share of Point of Care Diagnostics (POCD) from 2019 to 2024.
Chapter 3, the Point of Care Diagnostics (POCD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Point of Care Diagnostics (POCD) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Point of Care Diagnostics (POCD).
Chapter 13, to describe Point of Care Diagnostics (POCD) research findings and conclusion.
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Point of Care Diagnostics (POCD) industry chain, the market status of Clinics (Blood Glucose Testing, Infectious Diseases Testing), Hospitals (Blood Glucose Testing, Infectious Diseases Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point of Care Diagnostics (POCD).
Regionally, the report analyzes the Point of Care Diagnostics (POCD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point of Care Diagnostics (POCD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point of Care Diagnostics (POCD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point of Care Diagnostics (POCD) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Glucose Testing, Infectious Diseases Testing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point of Care Diagnostics (POCD) market.
Regional Analysis: The report involves examining the Point of Care Diagnostics (POCD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point of Care Diagnostics (POCD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point of Care Diagnostics (POCD):
Company Analysis: Report covers individual Point of Care Diagnostics (POCD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point of Care Diagnostics (POCD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinics, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Point of Care Diagnostics (POCD). It assesses the current state, advancements, and potential future developments in Point of Care Diagnostics (POCD) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point of Care Diagnostics (POCD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point of Care Diagnostics (POCD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Tumor Markers Testing
- Urinalysis Testing
- Cholesterol Testing
- Others
- Clinics
- Hospitals
- Assisted Living Healthcare Facilities
- Laboratory
- Alere
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- QIAGEN
- Bayer Healthcare
- Beckman Coulter
- Nipro Diagnostics
- Bio-Rad Laboratories
- Nova Biomedical
- BioMerieux
- Quidel
- Helena Laboratories
- OraSure Technologies
- Accriva
- Abaxis
- Chembio Diagnostics
- Trinity Biotech
- Instrumentation Laboratory
- Sekisui Diagnostics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Point of Care Diagnostics (POCD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point of Care Diagnostics (POCD), with revenue, gross margin and global market share of Point of Care Diagnostics (POCD) from 2019 to 2024.
Chapter 3, the Point of Care Diagnostics (POCD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Point of Care Diagnostics (POCD) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Point of Care Diagnostics (POCD).
Chapter 13, to describe Point of Care Diagnostics (POCD) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Point of Care Diagnostics (POCD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point of Care Diagnostics (POCD) by Type
1.3.1 Overview: Global Point of Care Diagnostics (POCD) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Type in 2023
1.3.3 Blood Glucose Testing
1.3.4 Infectious Diseases Testing
1.3.5 Cardiac Markers Testing
1.3.6 Coagulation Testing
1.3.7 Pregnancy and Fertility Testing
1.3.8 Blood Gas/Electrolytes Testing
1.3.9 Tumor Markers Testing
1.3.10 Urinalysis Testing
1.3.11 Cholesterol Testing
1.3.12 Others
1.4 Global Point of Care Diagnostics (POCD) Market by Application
1.4.1 Overview: Global Point of Care Diagnostics (POCD) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinics
1.4.3 Hospitals
1.4.4 Assisted Living Healthcare Facilities
1.4.5 Laboratory
1.5 Global Point of Care Diagnostics (POCD) Market Size & Forecast
1.6 Global Point of Care Diagnostics (POCD) Market Size and Forecast by Region
1.6.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Point of Care Diagnostics (POCD) Market Size by Region, (2019-2030)
1.6.3 North America Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.4 Europe Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.6 South America Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Alere
2.1.1 Alere Details
2.1.2 Alere Major Business
2.1.3 Alere Point of Care Diagnostics (POCD) Product and Solutions
2.1.4 Alere Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Alere Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Point of Care Diagnostics (POCD) Product and Solutions
2.2.4 Roche Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.3.4 Abbott Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Product and Solutions
2.4.4 Johnson & Johnson Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Product and Solutions
2.5.4 Siemens Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Siemens Healthcare Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Point of Care Diagnostics (POCD) Product and Solutions
2.6.4 Danaher Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Point of Care Diagnostics (POCD) Product and Solutions
2.7.4 QIAGEN Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Bayer Healthcare
2.8.1 Bayer Healthcare Details
2.8.2 Bayer Healthcare Major Business
2.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Product and Solutions
2.8.4 Bayer Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bayer Healthcare Recent Developments and Future Plans
2.9 Beckman Coulter
2.9.1 Beckman Coulter Details
2.9.2 Beckman Coulter Major Business
2.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Product and Solutions
2.9.4 Beckman Coulter Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Beckman Coulter Recent Developments and Future Plans
2.10 Nipro Diagnostics
2.10.1 Nipro Diagnostics Details
2.10.2 Nipro Diagnostics Major Business
2.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.10.4 Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nipro Diagnostics Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.11.4 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 Nova Biomedical
2.12.1 Nova Biomedical Details
2.12.2 Nova Biomedical Major Business
2.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Product and Solutions
2.12.4 Nova Biomedical Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Nova Biomedical Recent Developments and Future Plans
2.13 BioMerieux
2.13.1 BioMerieux Details
2.13.2 BioMerieux Major Business
2.13.3 BioMerieux Point of Care Diagnostics (POCD) Product and Solutions
2.13.4 BioMerieux Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 BioMerieux Recent Developments and Future Plans
2.14 Quidel
2.14.1 Quidel Details
2.14.2 Quidel Major Business
2.14.3 Quidel Point of Care Diagnostics (POCD) Product and Solutions
2.14.4 Quidel Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Quidel Recent Developments and Future Plans
2.15 Helena Laboratories
2.15.1 Helena Laboratories Details
2.15.2 Helena Laboratories Major Business
2.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.15.4 Helena Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Helena Laboratories Recent Developments and Future Plans
2.16 OraSure Technologies
2.16.1 OraSure Technologies Details
2.16.2 OraSure Technologies Major Business
2.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Product and Solutions
2.16.4 OraSure Technologies Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 OraSure Technologies Recent Developments and Future Plans
2.17 Accriva
2.17.1 Accriva Details
2.17.2 Accriva Major Business
2.17.3 Accriva Point of Care Diagnostics (POCD) Product and Solutions
2.17.4 Accriva Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Accriva Recent Developments and Future Plans
2.18 Abaxis
2.18.1 Abaxis Details
2.18.2 Abaxis Major Business
2.18.3 Abaxis Point of Care Diagnostics (POCD) Product and Solutions
2.18.4 Abaxis Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Abaxis Recent Developments and Future Plans
2.19 Chembio Diagnostics
2.19.1 Chembio Diagnostics Details
2.19.2 Chembio Diagnostics Major Business
2.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.19.4 Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Chembio Diagnostics Recent Developments and Future Plans
2.20 Trinity Biotech
2.20.1 Trinity Biotech Details
2.20.2 Trinity Biotech Major Business
2.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Product and Solutions
2.20.4 Trinity Biotech Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Trinity Biotech Recent Developments and Future Plans
2.21 Instrumentation Laboratory
2.21.1 Instrumentation Laboratory Details
2.21.2 Instrumentation Laboratory Major Business
2.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Product and Solutions
2.21.4 Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Instrumentation Laboratory Recent Developments and Future Plans
2.22 Sekisui Diagnostics
2.22.1 Sekisui Diagnostics Details
2.22.2 Sekisui Diagnostics Major Business
2.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.22.4 Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Sekisui Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Point of Care Diagnostics (POCD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Point of Care Diagnostics (POCD) by Company Revenue
3.2.2 Top 3 Point of Care Diagnostics (POCD) Players Market Share in 2023
3.2.3 Top 6 Point of Care Diagnostics (POCD) Players Market Share in 2023
3.3 Point of Care Diagnostics (POCD) Market: Overall Company Footprint Analysis
3.3.1 Point of Care Diagnostics (POCD) Market: Region Footprint
3.3.2 Point of Care Diagnostics (POCD) Market: Company Product Type Footprint
3.3.3 Point of Care Diagnostics (POCD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Point of Care Diagnostics (POCD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Point of Care Diagnostics (POCD) Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2024)
5.2 Global Point of Care Diagnostics (POCD) Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
6.2 North America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country
6.3.1 North America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
6.3.2 United States Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
6.3.3 Canada Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
6.3.4 Mexico Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
7.2 Europe Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country
7.3.1 Europe Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
7.3.2 Germany Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.3 France Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.5 Russia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.6 Italy Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
8.3.1 Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Region (2019-2030)
8.3.2 China Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.3 Japan Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.4 South Korea Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.5 India Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.7 Australia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
9.2 South America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
9.3 South America Point of Care Diagnostics (POCD) Market Size by Country
9.3.1 South America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
9.3.2 Brazil Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
9.3.3 Argentina Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
10.3.1 Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
10.3.2 Turkey Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
10.3.4 UAE Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Point of Care Diagnostics (POCD) Market Drivers
11.2 Point of Care Diagnostics (POCD) Market Restraints
11.3 Point of Care Diagnostics (POCD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Point of Care Diagnostics (POCD) Industry Chain
12.2 Point of Care Diagnostics (POCD) Upstream Analysis
12.3 Point of Care Diagnostics (POCD) Midstream Analysis
12.4 Point of Care Diagnostics (POCD) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Point of Care Diagnostics (POCD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point of Care Diagnostics (POCD) by Type
1.3.1 Overview: Global Point of Care Diagnostics (POCD) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Type in 2023
1.3.3 Blood Glucose Testing
1.3.4 Infectious Diseases Testing
1.3.5 Cardiac Markers Testing
1.3.6 Coagulation Testing
1.3.7 Pregnancy and Fertility Testing
1.3.8 Blood Gas/Electrolytes Testing
1.3.9 Tumor Markers Testing
1.3.10 Urinalysis Testing
1.3.11 Cholesterol Testing
1.3.12 Others
1.4 Global Point of Care Diagnostics (POCD) Market by Application
1.4.1 Overview: Global Point of Care Diagnostics (POCD) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinics
1.4.3 Hospitals
1.4.4 Assisted Living Healthcare Facilities
1.4.5 Laboratory
1.5 Global Point of Care Diagnostics (POCD) Market Size & Forecast
1.6 Global Point of Care Diagnostics (POCD) Market Size and Forecast by Region
1.6.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Point of Care Diagnostics (POCD) Market Size by Region, (2019-2030)
1.6.3 North America Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.4 Europe Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.6 South America Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Point of Care Diagnostics (POCD) Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Alere
2.1.1 Alere Details
2.1.2 Alere Major Business
2.1.3 Alere Point of Care Diagnostics (POCD) Product and Solutions
2.1.4 Alere Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Alere Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Point of Care Diagnostics (POCD) Product and Solutions
2.2.4 Roche Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.3.4 Abbott Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Product and Solutions
2.4.4 Johnson & Johnson Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Product and Solutions
2.5.4 Siemens Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Siemens Healthcare Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Point of Care Diagnostics (POCD) Product and Solutions
2.6.4 Danaher Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Point of Care Diagnostics (POCD) Product and Solutions
2.7.4 QIAGEN Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Bayer Healthcare
2.8.1 Bayer Healthcare Details
2.8.2 Bayer Healthcare Major Business
2.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Product and Solutions
2.8.4 Bayer Healthcare Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bayer Healthcare Recent Developments and Future Plans
2.9 Beckman Coulter
2.9.1 Beckman Coulter Details
2.9.2 Beckman Coulter Major Business
2.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Product and Solutions
2.9.4 Beckman Coulter Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Beckman Coulter Recent Developments and Future Plans
2.10 Nipro Diagnostics
2.10.1 Nipro Diagnostics Details
2.10.2 Nipro Diagnostics Major Business
2.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.10.4 Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nipro Diagnostics Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.11.4 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 Nova Biomedical
2.12.1 Nova Biomedical Details
2.12.2 Nova Biomedical Major Business
2.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Product and Solutions
2.12.4 Nova Biomedical Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Nova Biomedical Recent Developments and Future Plans
2.13 BioMerieux
2.13.1 BioMerieux Details
2.13.2 BioMerieux Major Business
2.13.3 BioMerieux Point of Care Diagnostics (POCD) Product and Solutions
2.13.4 BioMerieux Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 BioMerieux Recent Developments and Future Plans
2.14 Quidel
2.14.1 Quidel Details
2.14.2 Quidel Major Business
2.14.3 Quidel Point of Care Diagnostics (POCD) Product and Solutions
2.14.4 Quidel Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Quidel Recent Developments and Future Plans
2.15 Helena Laboratories
2.15.1 Helena Laboratories Details
2.15.2 Helena Laboratories Major Business
2.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Product and Solutions
2.15.4 Helena Laboratories Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Helena Laboratories Recent Developments and Future Plans
2.16 OraSure Technologies
2.16.1 OraSure Technologies Details
2.16.2 OraSure Technologies Major Business
2.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Product and Solutions
2.16.4 OraSure Technologies Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 OraSure Technologies Recent Developments and Future Plans
2.17 Accriva
2.17.1 Accriva Details
2.17.2 Accriva Major Business
2.17.3 Accriva Point of Care Diagnostics (POCD) Product and Solutions
2.17.4 Accriva Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Accriva Recent Developments and Future Plans
2.18 Abaxis
2.18.1 Abaxis Details
2.18.2 Abaxis Major Business
2.18.3 Abaxis Point of Care Diagnostics (POCD) Product and Solutions
2.18.4 Abaxis Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Abaxis Recent Developments and Future Plans
2.19 Chembio Diagnostics
2.19.1 Chembio Diagnostics Details
2.19.2 Chembio Diagnostics Major Business
2.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.19.4 Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Chembio Diagnostics Recent Developments and Future Plans
2.20 Trinity Biotech
2.20.1 Trinity Biotech Details
2.20.2 Trinity Biotech Major Business
2.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Product and Solutions
2.20.4 Trinity Biotech Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Trinity Biotech Recent Developments and Future Plans
2.21 Instrumentation Laboratory
2.21.1 Instrumentation Laboratory Details
2.21.2 Instrumentation Laboratory Major Business
2.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Product and Solutions
2.21.4 Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Instrumentation Laboratory Recent Developments and Future Plans
2.22 Sekisui Diagnostics
2.22.1 Sekisui Diagnostics Details
2.22.2 Sekisui Diagnostics Major Business
2.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
2.22.4 Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Sekisui Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Point of Care Diagnostics (POCD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Point of Care Diagnostics (POCD) by Company Revenue
3.2.2 Top 3 Point of Care Diagnostics (POCD) Players Market Share in 2023
3.2.3 Top 6 Point of Care Diagnostics (POCD) Players Market Share in 2023
3.3 Point of Care Diagnostics (POCD) Market: Overall Company Footprint Analysis
3.3.1 Point of Care Diagnostics (POCD) Market: Region Footprint
3.3.2 Point of Care Diagnostics (POCD) Market: Company Product Type Footprint
3.3.3 Point of Care Diagnostics (POCD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Point of Care Diagnostics (POCD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Point of Care Diagnostics (POCD) Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2024)
5.2 Global Point of Care Diagnostics (POCD) Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
6.2 North America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country
6.3.1 North America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
6.3.2 United States Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
6.3.3 Canada Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
6.3.4 Mexico Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
7.2 Europe Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country
7.3.1 Europe Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
7.3.2 Germany Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.3 France Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.5 Russia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
7.3.6 Italy Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
8.3.1 Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Region (2019-2030)
8.3.2 China Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.3 Japan Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.4 South Korea Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.5 India Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
8.3.7 Australia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
9.2 South America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
9.3 South America Point of Care Diagnostics (POCD) Market Size by Country
9.3.1 South America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
9.3.2 Brazil Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
9.3.3 Argentina Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
10.3.1 Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2030)
10.3.2 Turkey Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
10.3.4 UAE Point of Care Diagnostics (POCD) Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Point of Care Diagnostics (POCD) Market Drivers
11.2 Point of Care Diagnostics (POCD) Market Restraints
11.3 Point of Care Diagnostics (POCD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Point of Care Diagnostics (POCD) Industry Chain
12.2 Point of Care Diagnostics (POCD) Upstream Analysis
12.3 Point of Care Diagnostics (POCD) Midstream Analysis
12.4 Point of Care Diagnostics (POCD) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Point of Care Diagnostics (POCD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point of Care Diagnostics (POCD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Point of Care Diagnostics (POCD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Point of Care Diagnostics (POCD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Alere Company Information, Head Office, and Major Competitors
Table 6. Alere Major Business
Table 7. Alere Point of Care Diagnostics (POCD) Product and Solutions
Table 8. Alere Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Alere Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Point of Care Diagnostics (POCD) Product and Solutions
Table 13. Roche Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 18. Abbott Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Point of Care Diagnostics (POCD) Product and Solutions
Table 23. Johnson & Johnson Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 26. Siemens Healthcare Major Business
Table 27. Siemens Healthcare Point of Care Diagnostics (POCD) Product and Solutions
Table 28. Siemens Healthcare Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Siemens Healthcare Recent Developments and Future Plans
Table 30. Danaher Company Information, Head Office, and Major Competitors
Table 31. Danaher Major Business
Table 32. Danaher Point of Care Diagnostics (POCD) Product and Solutions
Table 33. Danaher Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Danaher Recent Developments and Future Plans
Table 35. QIAGEN Company Information, Head Office, and Major Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN Point of Care Diagnostics (POCD) Product and Solutions
Table 38. QIAGEN Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. QIAGEN Recent Developments and Future Plans
Table 40. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 41. Bayer Healthcare Major Business
Table 42. Bayer Healthcare Point of Care Diagnostics (POCD) Product and Solutions
Table 43. Bayer Healthcare Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bayer Healthcare Recent Developments and Future Plans
Table 45. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 46. Beckman Coulter Major Business
Table 47. Beckman Coulter Point of Care Diagnostics (POCD) Product and Solutions
Table 48. Beckman Coulter Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Beckman Coulter Recent Developments and Future Plans
Table 50. Nipro Diagnostics Company Information, Head Office, and Major Competitors
Table 51. Nipro Diagnostics Major Business
Table 52. Nipro Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 53. Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Nipro Diagnostics Recent Developments and Future Plans
Table 55. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 56. Bio-Rad Laboratories Major Business
Table 57. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 58. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Bio-Rad Laboratories Recent Developments and Future Plans
Table 60. Nova Biomedical Company Information, Head Office, and Major Competitors
Table 61. Nova Biomedical Major Business
Table 62. Nova Biomedical Point of Care Diagnostics (POCD) Product and Solutions
Table 63. Nova Biomedical Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Nova Biomedical Recent Developments and Future Plans
Table 65. BioMerieux Company Information, Head Office, and Major Competitors
Table 66. BioMerieux Major Business
Table 67. BioMerieux Point of Care Diagnostics (POCD) Product and Solutions
Table 68. BioMerieux Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. BioMerieux Recent Developments and Future Plans
Table 70. Quidel Company Information, Head Office, and Major Competitors
Table 71. Quidel Major Business
Table 72. Quidel Point of Care Diagnostics (POCD) Product and Solutions
Table 73. Quidel Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Quidel Recent Developments and Future Plans
Table 75. Helena Laboratories Company Information, Head Office, and Major Competitors
Table 76. Helena Laboratories Major Business
Table 77. Helena Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 78. Helena Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Helena Laboratories Recent Developments and Future Plans
Table 80. OraSure Technologies Company Information, Head Office, and Major Competitors
Table 81. OraSure Technologies Major Business
Table 82. OraSure Technologies Point of Care Diagnostics (POCD) Product and Solutions
Table 83. OraSure Technologies Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. OraSure Technologies Recent Developments and Future Plans
Table 85. Accriva Company Information, Head Office, and Major Competitors
Table 86. Accriva Major Business
Table 87. Accriva Point of Care Diagnostics (POCD) Product and Solutions
Table 88. Accriva Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Accriva Recent Developments and Future Plans
Table 90. Abaxis Company Information, Head Office, and Major Competitors
Table 91. Abaxis Major Business
Table 92. Abaxis Point of Care Diagnostics (POCD) Product and Solutions
Table 93. Abaxis Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Abaxis Recent Developments and Future Plans
Table 95. Chembio Diagnostics Company Information, Head Office, and Major Competitors
Table 96. Chembio Diagnostics Major Business
Table 97. Chembio Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 98. Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Chembio Diagnostics Recent Developments and Future Plans
Table 100. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 101. Trinity Biotech Major Business
Table 102. Trinity Biotech Point of Care Diagnostics (POCD) Product and Solutions
Table 103. Trinity Biotech Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Trinity Biotech Recent Developments and Future Plans
Table 105. Instrumentation Laboratory Company Information, Head Office, and Major Competitors
Table 106. Instrumentation Laboratory Major Business
Table 107. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product and Solutions
Table 108. Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Instrumentation Laboratory Recent Developments and Future Plans
Table 110. Sekisui Diagnostics Company Information, Head Office, and Major Competitors
Table 111. Sekisui Diagnostics Major Business
Table 112. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 113. Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Sekisui Diagnostics Recent Developments and Future Plans
Table 115. Global Point of Care Diagnostics (POCD) Revenue (USD Million) by Players (2019-2024)
Table 116. Global Point of Care Diagnostics (POCD) Revenue Share by Players (2019-2024)
Table 117. Breakdown of Point of Care Diagnostics (POCD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Point of Care Diagnostics (POCD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key Point of Care Diagnostics (POCD) Players
Table 120. Point of Care Diagnostics (POCD) Market: Company Product Type Footprint
Table 121. Point of Care Diagnostics (POCD) Market: Company Product Application Footprint
Table 122. Point of Care Diagnostics (POCD) New Market Entrants and Barriers to Market Entry
Table 123. Point of Care Diagnostics (POCD) Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Point of Care Diagnostics (POCD) Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global Point of Care Diagnostics (POCD) Consumption Value Share by Type (2019-2024)
Table 126. Global Point of Care Diagnostics (POCD) Consumption Value Forecast by Type (2025-2030)
Table 127. Global Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024)
Table 128. Global Point of Care Diagnostics (POCD) Consumption Value Forecast by Application (2025-2030)
Table 129. North America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Point of Care Diagnostics (POCD) Raw Material
Table 160. Key Suppliers of Point of Care Diagnostics (POCD) Raw Materials
Table 1. Global Point of Care Diagnostics (POCD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point of Care Diagnostics (POCD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Point of Care Diagnostics (POCD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Point of Care Diagnostics (POCD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Alere Company Information, Head Office, and Major Competitors
Table 6. Alere Major Business
Table 7. Alere Point of Care Diagnostics (POCD) Product and Solutions
Table 8. Alere Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Alere Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Point of Care Diagnostics (POCD) Product and Solutions
Table 13. Roche Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 18. Abbott Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Point of Care Diagnostics (POCD) Product and Solutions
Table 23. Johnson & Johnson Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 26. Siemens Healthcare Major Business
Table 27. Siemens Healthcare Point of Care Diagnostics (POCD) Product and Solutions
Table 28. Siemens Healthcare Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Siemens Healthcare Recent Developments and Future Plans
Table 30. Danaher Company Information, Head Office, and Major Competitors
Table 31. Danaher Major Business
Table 32. Danaher Point of Care Diagnostics (POCD) Product and Solutions
Table 33. Danaher Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Danaher Recent Developments and Future Plans
Table 35. QIAGEN Company Information, Head Office, and Major Competitors
Table 36. QIAGEN Major Business
Table 37. QIAGEN Point of Care Diagnostics (POCD) Product and Solutions
Table 38. QIAGEN Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. QIAGEN Recent Developments and Future Plans
Table 40. Bayer Healthcare Company Information, Head Office, and Major Competitors
Table 41. Bayer Healthcare Major Business
Table 42. Bayer Healthcare Point of Care Diagnostics (POCD) Product and Solutions
Table 43. Bayer Healthcare Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bayer Healthcare Recent Developments and Future Plans
Table 45. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 46. Beckman Coulter Major Business
Table 47. Beckman Coulter Point of Care Diagnostics (POCD) Product and Solutions
Table 48. Beckman Coulter Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Beckman Coulter Recent Developments and Future Plans
Table 50. Nipro Diagnostics Company Information, Head Office, and Major Competitors
Table 51. Nipro Diagnostics Major Business
Table 52. Nipro Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 53. Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Nipro Diagnostics Recent Developments and Future Plans
Table 55. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 56. Bio-Rad Laboratories Major Business
Table 57. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 58. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Bio-Rad Laboratories Recent Developments and Future Plans
Table 60. Nova Biomedical Company Information, Head Office, and Major Competitors
Table 61. Nova Biomedical Major Business
Table 62. Nova Biomedical Point of Care Diagnostics (POCD) Product and Solutions
Table 63. Nova Biomedical Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Nova Biomedical Recent Developments and Future Plans
Table 65. BioMerieux Company Information, Head Office, and Major Competitors
Table 66. BioMerieux Major Business
Table 67. BioMerieux Point of Care Diagnostics (POCD) Product and Solutions
Table 68. BioMerieux Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. BioMerieux Recent Developments and Future Plans
Table 70. Quidel Company Information, Head Office, and Major Competitors
Table 71. Quidel Major Business
Table 72. Quidel Point of Care Diagnostics (POCD) Product and Solutions
Table 73. Quidel Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Quidel Recent Developments and Future Plans
Table 75. Helena Laboratories Company Information, Head Office, and Major Competitors
Table 76. Helena Laboratories Major Business
Table 77. Helena Laboratories Point of Care Diagnostics (POCD) Product and Solutions
Table 78. Helena Laboratories Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Helena Laboratories Recent Developments and Future Plans
Table 80. OraSure Technologies Company Information, Head Office, and Major Competitors
Table 81. OraSure Technologies Major Business
Table 82. OraSure Technologies Point of Care Diagnostics (POCD) Product and Solutions
Table 83. OraSure Technologies Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. OraSure Technologies Recent Developments and Future Plans
Table 85. Accriva Company Information, Head Office, and Major Competitors
Table 86. Accriva Major Business
Table 87. Accriva Point of Care Diagnostics (POCD) Product and Solutions
Table 88. Accriva Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Accriva Recent Developments and Future Plans
Table 90. Abaxis Company Information, Head Office, and Major Competitors
Table 91. Abaxis Major Business
Table 92. Abaxis Point of Care Diagnostics (POCD) Product and Solutions
Table 93. Abaxis Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Abaxis Recent Developments and Future Plans
Table 95. Chembio Diagnostics Company Information, Head Office, and Major Competitors
Table 96. Chembio Diagnostics Major Business
Table 97. Chembio Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 98. Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Chembio Diagnostics Recent Developments and Future Plans
Table 100. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 101. Trinity Biotech Major Business
Table 102. Trinity Biotech Point of Care Diagnostics (POCD) Product and Solutions
Table 103. Trinity Biotech Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Trinity Biotech Recent Developments and Future Plans
Table 105. Instrumentation Laboratory Company Information, Head Office, and Major Competitors
Table 106. Instrumentation Laboratory Major Business
Table 107. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product and Solutions
Table 108. Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Instrumentation Laboratory Recent Developments and Future Plans
Table 110. Sekisui Diagnostics Company Information, Head Office, and Major Competitors
Table 111. Sekisui Diagnostics Major Business
Table 112. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product and Solutions
Table 113. Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Sekisui Diagnostics Recent Developments and Future Plans
Table 115. Global Point of Care Diagnostics (POCD) Revenue (USD Million) by Players (2019-2024)
Table 116. Global Point of Care Diagnostics (POCD) Revenue Share by Players (2019-2024)
Table 117. Breakdown of Point of Care Diagnostics (POCD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Point of Care Diagnostics (POCD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key Point of Care Diagnostics (POCD) Players
Table 120. Point of Care Diagnostics (POCD) Market: Company Product Type Footprint
Table 121. Point of Care Diagnostics (POCD) Market: Company Product Application Footprint
Table 122. Point of Care Diagnostics (POCD) New Market Entrants and Barriers to Market Entry
Table 123. Point of Care Diagnostics (POCD) Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Point of Care Diagnostics (POCD) Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global Point of Care Diagnostics (POCD) Consumption Value Share by Type (2019-2024)
Table 126. Global Point of Care Diagnostics (POCD) Consumption Value Forecast by Type (2025-2030)
Table 127. Global Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024)
Table 128. Global Point of Care Diagnostics (POCD) Consumption Value Forecast by Application (2025-2030)
Table 129. North America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa Point of Care Diagnostics (POCD) Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Point of Care Diagnostics (POCD) Raw Material
Table 160. Key Suppliers of Point of Care Diagnostics (POCD) Raw Materials
LIST OF FIGURES
Figure 1. Point of Care Diagnostics (POCD) Picture
Figure 2. Global Point of Care Diagnostics (POCD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Type in 2023
Figure 4. Blood Glucose Testing
Figure 5. Infectious Diseases Testing
Figure 6. Cardiac Markers Testing
Figure 7. Coagulation Testing
Figure 8. Pregnancy and Fertility Testing
Figure 9. Blood Gas/Electrolytes Testing
Figure 10. Tumor Markers Testing
Figure 11. Urinalysis Testing
Figure 12. Cholesterol Testing
Figure 13. Others
Figure 14. Global Point of Care Diagnostics (POCD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 15. Point of Care Diagnostics (POCD) Consumption Value Market Share by Application in 2023
Figure 16. Clinics Picture
Figure 17. Hospitals Picture
Figure 18. Assisted Living Healthcare Facilities Picture
Figure 19. Laboratory Picture
Figure 20. Global Point of Care Diagnostics (POCD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 21. Global Point of Care Diagnostics (POCD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 22. Global Market Point of Care Diagnostics (POCD) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 23. Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Region (2019-2030)
Figure 24. Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Region in 2023
Figure 25. North America Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Point of Care Diagnostics (POCD) Revenue Share by Players in 2023
Figure 31. Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 32. Global Top 3 Players Point of Care Diagnostics (POCD) Market Share in 2023
Figure 33. Global Top 6 Players Point of Care Diagnostics (POCD) Market Share in 2023
Figure 34. Global Point of Care Diagnostics (POCD) Consumption Value Share by Type (2019-2024)
Figure 35. Global Point of Care Diagnostics (POCD) Market Share Forecast by Type (2025-2030)
Figure 36. Global Point of Care Diagnostics (POCD) Consumption Value Share by Application (2019-2024)
Figure 37. Global Point of Care Diagnostics (POCD) Market Share Forecast by Application (2025-2030)
Figure 38. North America Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 39. North America Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 40. North America Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 42. Canada Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 43. Mexico Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 44. Europe Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 45. Europe Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 46. Europe Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 48. France Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value Market Share by Region (2019-2030)
Figure 55. China Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Japan Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 57. South Korea Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 58. India Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 59. Southeast Asia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 60. Australia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 61. South America Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 62. South America Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 63. South America Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 65. Argentina Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 66. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 67. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 68. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 71. UAE Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 72. Point of Care Diagnostics (POCD) Market Drivers
Figure 73. Point of Care Diagnostics (POCD) Market Restraints
Figure 74. Point of Care Diagnostics (POCD) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Point of Care Diagnostics (POCD) in 2023
Figure 77. Manufacturing Process Analysis of Point of Care Diagnostics (POCD)
Figure 78. Point of Care Diagnostics (POCD) Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source
Figure 1. Point of Care Diagnostics (POCD) Picture
Figure 2. Global Point of Care Diagnostics (POCD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Type in 2023
Figure 4. Blood Glucose Testing
Figure 5. Infectious Diseases Testing
Figure 6. Cardiac Markers Testing
Figure 7. Coagulation Testing
Figure 8. Pregnancy and Fertility Testing
Figure 9. Blood Gas/Electrolytes Testing
Figure 10. Tumor Markers Testing
Figure 11. Urinalysis Testing
Figure 12. Cholesterol Testing
Figure 13. Others
Figure 14. Global Point of Care Diagnostics (POCD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 15. Point of Care Diagnostics (POCD) Consumption Value Market Share by Application in 2023
Figure 16. Clinics Picture
Figure 17. Hospitals Picture
Figure 18. Assisted Living Healthcare Facilities Picture
Figure 19. Laboratory Picture
Figure 20. Global Point of Care Diagnostics (POCD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 21. Global Point of Care Diagnostics (POCD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 22. Global Market Point of Care Diagnostics (POCD) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 23. Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Region (2019-2030)
Figure 24. Global Point of Care Diagnostics (POCD) Consumption Value Market Share by Region in 2023
Figure 25. North America Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Point of Care Diagnostics (POCD) Revenue Share by Players in 2023
Figure 31. Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 32. Global Top 3 Players Point of Care Diagnostics (POCD) Market Share in 2023
Figure 33. Global Top 6 Players Point of Care Diagnostics (POCD) Market Share in 2023
Figure 34. Global Point of Care Diagnostics (POCD) Consumption Value Share by Type (2019-2024)
Figure 35. Global Point of Care Diagnostics (POCD) Market Share Forecast by Type (2025-2030)
Figure 36. Global Point of Care Diagnostics (POCD) Consumption Value Share by Application (2019-2024)
Figure 37. Global Point of Care Diagnostics (POCD) Market Share Forecast by Application (2025-2030)
Figure 38. North America Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 39. North America Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 40. North America Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 42. Canada Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 43. Mexico Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 44. Europe Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 45. Europe Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 46. Europe Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 48. France Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Point of Care Diagnostics (POCD) Consumption Value Market Share by Region (2019-2030)
Figure 55. China Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Japan Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 57. South Korea Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 58. India Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 59. Southeast Asia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 60. Australia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 61. South America Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 62. South America Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 63. South America Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 65. Argentina Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 66. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value Market Share by Type (2019-2030)
Figure 67. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value Market Share by Application (2019-2030)
Figure 68. Middle East and Africa Point of Care Diagnostics (POCD) Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 71. UAE Point of Care Diagnostics (POCD) Consumption Value (2019-2030) & (USD Million)
Figure 72. Point of Care Diagnostics (POCD) Market Drivers
Figure 73. Point of Care Diagnostics (POCD) Market Restraints
Figure 74. Point of Care Diagnostics (POCD) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Point of Care Diagnostics (POCD) in 2023
Figure 77. Manufacturing Process Analysis of Point of Care Diagnostics (POCD)
Figure 78. Point of Care Diagnostics (POCD) Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source
